High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

…, S Fattori, MA Hospital, J Pakradouni… - Proceedings of the …, 2021 - National Acad Sciences
Natural killer (NK) cells are major antileukemic immune effectors. Leukemic blasts have a
negative impact on NK cell function and promote the emergence of phenotypically and …

[HTML][HTML] PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer

…, M Campone, A Autret, J Pakradouni… - European Journal of …, 2017 - Elsevier
Background Phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin
pathway is frequently activated in HER2-positive breast cancer and may play a major role in …

[HTML][HTML] Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

…, C Vicier, E Mamessier, C Chabannon, J Pakradouni… - Genome Medicine, 2021 - Springer
Background The benefit of precision medicine based on relatively limited gene sets and
often-archived samples remains unproven. PERMED-01 (NCT02342158) was a prospective …

[HTML][HTML] Plasma NOV/CCN3 levels are closely associated with obesity in patients with metabolic disorders

J Pakradouni, W Le Goff, C Calmel, B Antoine… - PloS one, 2013 - journals.plos.org
Objective Evidence points to a founder of the multifunctional CCN family, NOV/CCN3, as a
circulating molecule involved in cardiac development, vascular homeostasis and inflammation…

[HTML][HTML] CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

…, A Ben Amara, N Boucherit, C Tarpin, J Pakradouni… - Cancer Research, 2023 - AACR
An imbalance between effector CD8 + T cells and CD25 high effector Tregs marks
immunosuppressive microenvironments in αPD-1–resistant TNBC and can be reversed through …

[HTML][HTML] Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset …

…, S Garnier, A Guille, N Carbuccia, J Pakradouni… - Frontiers in …, 2022 - frontiersin.org
Introduction. The poor prognosis of ovarian carcinoma is due to advanced stage at diagnosis,
a high risk of relapse after first-line therapies, and the lack of efficient treatments in the …

[HTML][HTML] TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2 …

…, M Chaffanet, D Birnbaum, J Pakradouni… - European Journal of …, 2021 - Elsevier
Background Hormone-resistant HER2-negative or triple-negative advanced breast cancers (ABC)
are routinely treated with paclitaxel chemotherapy. LY2780301 is a dual inhibitor of …

[HTML][HTML] The psychological distress of cancer patients following the COVID-19 pandemic first lockdown: results from a large French survey

P Marino, R Touzani, J Pakradouni, P Ben Soussan… - Cancers, 2022 - mdpi.com
Simple Summary Cancer patients commonly experience anxiety which could increase with
the COVID-19 pandemic situation. The aim of this study was to measure post-traumatic stress …

Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents

M Abifadel, J Pakradouni, M Collin… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Proprotein convertase subtilisin kexin 9 (PCSK9) is a new actor
discovered in 2003 that is implicated in autosomal dominant hypercholesterolemia, cholesterol …

[HTML][HTML] A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation

…, S Justafré, J Pakradouni… - Bone Marrow …, 2021 - nature.com
A need for social support is often expressed after hospitalization post HSCT. Emotional
support and positive psychological constructs play an important role in post-HSCT recovery. …